Maple Drug Substances And Products Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 30.90%
- Ebitda 50.93%
- Net Worth -4.69%
- Total Assets -1.01%
About Maple Drug Substances And Products
Maple Drug Substances And Products Private Limited (MDSAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 September 2020 (Four years and four months 20 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Hardev Nandepu, Harsha Nandepu, Veera Nandepu, and One other member serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33110TG2020PTC143892
-
Company No.
143892
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Sep 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Maple Drug Substances And Products?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hardev Nandepu
|
Director | 14-Sep-2020 | Current |
|
Harsha Nandepu
|
Director | 14-Sep-2020 | Current |
|
Veera Nandepu
|
Director | 14-Sep-2020 | Current |
|
Venkateswara Nandepu
|
Director | 14-Sep-2020 | Current |
Financial Performance of Maple Drug Substances And Products.
Maple Drug Substances And Products Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 30.9% increase in profit. The company's net worth dipped by a decrease of 4.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maple Drug Substances And Products?
Unlock access to Maple Drug Substances And Products's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Metrochem Api Private LimitedHardev Nandepu, Harsha Nandepu and 2 more are mutual person
-
Vijayalakshmi Investments & Holdings Private LimitedVeera Nandepu and Venkateswara Nandepu are mutual person
-
Organo Metallics Private Limited
Veera Nandepu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Maple Drug Substances And Products?
Maple Drug Substances And Products has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maple Drug Substances And Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maple Drug Substances And Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.